Unionview, LLC Pfizer Inc Transaction History

Unionview, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 23, 2024	SELL	$26.13 - $33.94 $17,585 - $22,841	-673 Reduced 8.35%	7,391 $212,000
Q3 2023 Oct 30, 2023	SELL	$32.09 - $37.51 $11,809 - $13,803	-368 Reduced 4.36%	8,064 $267,000
Q2 2023 Jul 25, 2023	BUY	$36.12 - $41.79 $3,539 - $4,095	98 Added 1.18%	8,432 $309,000
Q1 2023 May 01, 2023	BUY	$39.39 - $51.28 $9,296 - $12,102	236 Added 2.91%	8,334 $340,000
Q4 2022 Feb 09, 2023	BUY	$41.75 - $54.5 $3,298 - $4,305	79 Added 0.99%	8,098 $415,000
Q3 2022 Nov 14, 2022	SELL	$43.76 - $53.42 $7,132 - $8,707	-163 Reduced 1.99%	8,019 $351,000
Q2 2022 Aug 09, 2022	BUY	$46.53 - $55.17 $30,337 - $35,970	652 Added 8.66%	8,182 $429,000
Q1 2022 May 16, 2022	BUY	$45.75 - $56.69 $5,535 - $6,859	121 Added 1.63%	7,530 $390,000
Q4 2021 Feb 11, 2022	BUY	$41.32 - $61.25 $306,139 - $453,801	7,409 New	7,409 $438,000

3,218

3.71B

73.2M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $166B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Unionview, LLC, based on Form 13F filings with the SEC.

Stay updated on Unionview, LLC with notifications on news.